Prempro - 0046-1107-11 - (CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE)

Alphabetical Index


Drug Information of Prempro

Product NDC: 0046-1107
Proprietary Name: Prempro
Non Proprietary Name: CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE
Active Ingredient(s): .625; 2.5    mg/1; mg/1 & nbsp;   CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE
Administration Route(s): ORAL
Dosage Form(s): TABLET, SUGAR COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Prempro

Product NDC: 0046-1107
Labeler Name: Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020527
Marketing Category: NDA
Start Marketing Date: 20090921

Package Information of Prempro

Package NDC: 0046-1107-11
Package Description: 1 BLISTER PACK in 1 CARTON (0046-1107-11) > 28 TABLET, SUGAR COATED in 1 BLISTER PACK

NDC Information of Prempro

NDC Code 0046-1107-11
Proprietary Name Prempro
Package Description 1 BLISTER PACK in 1 CARTON (0046-1107-11) > 28 TABLET, SUGAR COATED in 1 BLISTER PACK
Product NDC 0046-1107
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE
Dosage Form Name TABLET, SUGAR COATED
Route Name ORAL
Start Marketing Date 20090921
Marketing Category Name NDA
Labeler Name Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.
Substance Name ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE
Strength Number .625; 2.5
Strength Unit mg/1; mg/1
Pharmaceutical Classes Estrogen [EPC],Estrogen Receptor Agonists [MoA],Estrogens, Conjugated (USP) [Chemical/Ingredient],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC]

Complete Information of Prempro


General Information